TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,740.00
-50.00 (-0.74%)
At close: Mar 9, 2026

TiumBio Revenue

TiumBio had revenue of 3.12B KRW in the quarter ending September 30, 2025, with 175.77% growth. This brings the company's revenue in the last twelve months to 9.32B, up 21.54% year-over-year. In the year 2024, TiumBio had annual revenue of 6.79B with 38.65% growth.

Revenue (ttm)
9.32B
Revenue Growth
+21.54%
P/S Ratio
21.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
195.99B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.79B1.89B38.65%
Dec 31, 20234.90B-4.22B-46.27%
Dec 31, 20229.12B9.06B15,952.75%
Dec 31, 202156.80M-992.15M-94.59%
Dec 31, 20201.05B-64.05M-5.75%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Prestige Biologics 19.24B
Ensol Biosciences 537.46M
ISU Abxis 66.39B
Kangstem Biotech 12.77B
QuadMedicine 13.11B
Genome & Company 25.95B
ABION 1.03B
Bio Solution 8.27B
Revenue Rankings